LSX World Congress
The 10th LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core.
The 10th LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core.
In one of the opening workshops at ASGCT 2024, topics around delivery methods for gene therapies and approaches to expand the gene editing toolbox dominated…
Casey Ross and Bob Herman report on how UnitedHealth Group used an unregulated algorithm to deny care to seriously ill older and disabled patients.
An optogenetic tool to enable the study of rapid inflammasome responses is described.
Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate fordadistrogene movaparvovec after acknowledging the sudden death…
The group practice’s SVP of digital health reveals how she and her team have created new care models, integrated artificial intelligence-enabled clinical decision support and…
The quarter marks the first time the company reported profitability on an adjusted EBITDA basis.
Money for new repatriation program would be better spent supporting researchers who stayed in Brazil, critics say
John Nosta, un visionnaire et philosophe que je suis avec passion, explore dans deux articles percutants l’impact de l’intelligence artificielle sur l’expansion des capacités humaines.…
Trained using more than 100,000 echocardiograms from atrial fibrillation cases, the algorithm has shown its ability to predict which patients could develop irregular heart rhythms…